Bone tumor identified in the rib of 120,000-year-old Neandertal The first-known definitive case of a benign bone tumor has been uncovered in the rib of a Neandertal who resided about 120,000 years back in what’s present-day Croatia now 24 ore . The bone fragment, which originates from the popular archaeological cave site of Krapina, contains by much the initial bone tumor ever recognized in the archaeological record. Information on the tumor confirmation, announced by a global research group led by Penn Museum Associate Paleoanthropologist and Curator Janet Monge, comes in a extensive study paper, Fibrous dysplasia in a 120,000+ year older Neandertal from Krapina, Croatia, in the web scientific journal PLOS ONE.

HSPH’s Kassandra Munger, analysis associate in the Division of Nutrition, was a co-author on the analysis. Funding for the analysis originated from the National Institute of Neurological Illnesses and Stroke and the National Multiple Sclerosis Culture. Supplement D as an early on predictor of multiple sclerosis activity and progression, Alberto Ascherio, Kassandra L. Polman, Tag S. Freedman, Hans-Peter Hartung, David H.. Boosting vitamin D can slow progression, decrease severity of multiple sclerosis For sufferers in the early phases of multiple sclerosis , low degrees of vitamin D were found to strongly predict disease severity and hasten its progression, according to a fresh research led by Harvard College of General public Health investigators in collaboration with Bayer HealthCare.